Home » January /February 2023 » Navigating a complex life sciences environment in 2023
2023 | January /February 2023

Navigating a complex life sciences environment in 2023

by cyb2025
M. Lane, R. Scharf
Fundraising
globalization
investors
outsourcing
partnerships
Pharma Supply Chain
product differentiation
product repurposing
target product profile (TPP)
virtualization

MARK LANE1, RAMI SCHARF2
1. Vice President of Development Consulting and Scientific Affairs, PharmaLex, Mannheim, Germany
2. Senior Director Development Consulting and Scientific Affairs, PharmaLex, Mannheim, Germany

ABSTRACT

Competition, complex new science and regulatory changes have been compounded by economic tightening. In 2023 and beyond, smaller biopharma companies in particular will need to rethink their strategies to attract investors, carefully plan how and with whom they outsource and ensure they understand the finer nuances of the regulations when they seek to globalize. Mark Lane and Rami Scharf of PharmaLex describe the challenges ahead.

The demands on life sciences companies are constantly intensifying. Resource constraints – whether workforce or the need to cut costs or streamline processes – different global regulatory requirements and the need to stay on top of technology advances create an increasingly complex environment for the industry.

ABOUT THE AUTHOR

Mark Lane, Ph.D., is Vice President of Development Consulting and Scientific Affairs at PharmaLex, where he draws on his experience with leading product development teams and functions accountable for product development across all phases to help clients of all sizes better manage their development processes.

Rami Scharf, D.Sc., is Senior Director Development Consulting and Scientific Affairs at PharmaLex, drawing on an international background in biopharma settings supporting early-stage products to late-stage registration activities and managing large scale projects in general.

Latest issue

November /December 2025

View Issue

Archive

For an even more in-depth scientific analysis, consult the archive

Chemistry Today - Archive
Go to archive

Content from magazine

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.
View all content

Most popular

@2026 - All Right Reserved.

Login